Cargando…
Prenatal circulating microRNA signatures of foetal Down syndrome
The altered expression pattern of miRNAs might potentially reflect anomalies related to foetal chromosomal aberrations. The aim of the study was to determine the expression level of miRNAs in plasma of pregnant women with foetal Down syndrome (DS). Out of 198 amniocentesis performed at 15–18 weeks o...
Autores principales: | Zbucka-Kretowska, Monika, Niemira, Magdalena, Paczkowska-Abdulsalam, Magdalena, Bielska, Agnieszka, Szalkowska, Anna, Parfieniuk, Ewa, Ciborowski, Michal, Wolczynski, Slawomir, Kretowski, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382869/ https://www.ncbi.nlm.nih.gov/pubmed/30787377 http://dx.doi.org/10.1038/s41598-018-35876-5 |
Ejemplares similares
-
Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2017) -
Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2015) -
miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus
por: Juchnicka, Ilona, et al.
Publicado: (2022) -
Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome
por: Laudanski, Piotr, et al.
Publicado: (2014) -
Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2016)